Medicare Enrolled

Dr. Mohammed Abubaker, MD

Internal Medicine · Marietta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
670 NORTH AVE NW, Marietta, GA 30060
7705908328
In practice since 2005 (20 years)
NPI: 1396733796 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abubaker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abubaker? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abubaker

Dr. Mohammed Abubaker is an internal medicine specialist in Marietta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Abubaker performed 74,005 Medicare services across 1,270 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abubaker received a total of $324,427 from 55 pharmaceutical and/or device companies across 1804 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abubaker is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in GA $324,427 industry payments

Medicare Practice Summary

Medicare Utilization ↗
74,005
Medicare services
Top 0% in GA for internal medicine
1,270
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,700 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
40,250 $10 $40
Denosumab injection (Prolia/Xgeva) 13,440 $18 $28
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
7,725 $34 $70
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
4,890 $26 $120
Hymovis intra-articular injection
An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space.
3,984 $13 $37
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
567 $89 $246
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
542 $1 $20
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
503 $1 $5
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
378 $11 $40
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
366 $8 $14
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
322 $52 $300
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
220 $106 $600
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
204 $23 $200
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
177 $62 $250
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
159 $64 $177
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
104 $41 $150
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
65 $12 $35
Knee X-ray, 1-2 views
An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures.
36 $25 $110
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
34 $3 $15
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
25 $107 $342
X-ray of both knees, standing
An X-ray image of both knees taken while the patient is standing to assess bone alignment and joint space under weight-bearing conditions.
14 $30 $106
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
72.9% high complexity
25.5% medium
1.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$324,427
Total received (2018-2024)
Avg $46,347/year across 7 years
Top 0% in GA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
1,804
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$245,175 (75.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$63,814 (19.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,438 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,543
2023
$15,960
2022
$27,088
2021
$24,333
2020
$51,733
2019
$80,624
2018
$109,146

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$6,398
Janssen Biotech, Inc.
$3,467
Novartis Pharmaceuticals Corporation
$3,282
Amgen Inc.
$756
UCB, Inc.
$439
ANI Pharmaceuticals, Inc.
$267
GlaxoSmithKline, LLC.
$195
Lilly USA, LLC
$114
PFIZER INC.
$110
Mallinckrodt Hospital Products Inc.
$103
AstraZeneca Pharmaceuticals LP
$88
Aurinia Pharma U.S., Inc.
$85
Genentech USA, Inc.
$57
SOBI, INC
$38
Sandoz Inc.
$34
Radius Health, Inc.
$32
Organon Llc
$22
E.R. Squibb & Sons, L.L.C.
$22
Abbott Laboratories
$19
Actelion Pharmaceuticals US, Inc.
$15
Top 3 companies account for 84.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$70,642
AbbVie Inc.
$32,378
GENZYME CORPORATION
$26,280
AbbVie, Inc.
$25,201
ABBVIE INC.
$24,199
UCB, Inc.
$22,079
Mallinckrodt Hospital Products Inc.
$21,713
E.R. Squibb & Sons, L.L.C.
$17,462
Mallinckrodt LLC
$13,779
Janssen Biotech, Inc.
$12,523
Boehringer Ingelheim Pharmaceuticals, Inc.
$9,934
Mallinckrodt Enterprises LLC
$8,822
Lilly USA, LLC
$8,677
Horizon Pharma plc
$5,242
Horizon Therapeutics plc
$4,447
Sandoz Inc.
$4,189
Amgen Inc.
$3,842
Regeneron Healthcare Solutions, Inc.
$3,749
Janssen Global Services, LLC
$2,000
PFIZER INC.
$1,339
Celgene Corporation
$694
Janssen Scientific Affairs, LLC
$635
Genentech USA, Inc.
$606
GlaxoSmithKline, LLC.
$517
AstraZeneca Pharmaceuticals LP
$444
DePuy Synthes Sales Inc.
$416
Radius Health, Inc.
$377
ANI Pharmaceuticals, Inc.
$344
SANOFI-AVENTIS U.S. LLC
$290
Aurinia Pharma U.S., Inc.
$254
Gilead Sciences, Inc.
$237
Antares Pharma, Inc.
$216
Ironwood Pharmaceuticals, Inc
$118
MEDAC PHARMA, INC.
$113
Genentech, Inc.
$92
Arcutis Biotherapeutics, Inc.
$82
MEDEXUS PHARMA, INC.
$79
Novo Nordisk Inc
$49
Ultragenyx Pharmaceutical Inc.
$43
SOBI, INC
$38
Merck Sharp & Dohme Corporation
$34
Organon LLC
$34
Egalet US Inc
$24
Organon Llc
$22
Abbott Laboratories
$19
Alexion Pharmaceuticals, Inc.
$19
Octapharma USA, Inc.
$19
Fidia Pharma USA Inc.
$18
Mylan Institutional Inc.
$18
Orthogenrx Inc.
$17
Ferring Pharmaceuticals Inc.
$16
Actelion Pharmaceuticals US, Inc.
$15
Kiniksa Pharmaceuticals, Ltd.
$14
Sobi, Inc
$12
FIDIA PHARMA USA INC.
$3
Top 3 companies account for 39.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · Cimzia · DUEXIS · DUZALLO · EUFLEXXA · EVENITY · Enbrel · FARXIGA · FORTEO · GenVisc 850 · HUMIRA · HYALGAN · HYMOVIS · HYRIMOZ · Humira · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · Ozempic · PENNSAID · PROCLAIM · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tymlos · XELJANZ · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in GA.

Looking for an internal medicine specialist in Marietta?
Compare internal medicine physicians in the Marietta area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,969
Per 100K population
256.0
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abubaker is a mixed practice specialist, with above-average Medicare volume (top 0% in GA), with speaking/promotional industry engagement in the top 0% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Abubaker experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Abubaker performed 40,250 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abubaker receive payments from pharmaceutical companies?
Yes. Dr. Abubaker received a total of $324,427 from 55 companies across 1,804 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abubaker's costs compare to other internal medicine physicians in Marietta?
Dr. Abubaker's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abubaker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →